Kyno

Minocycline Hydrochloride, the active ingredient in Kyno, is a tetracycline antibiotic presented as an oral tablet for systemic use. It treats bacterial infections such as acne vulgaris, skin and soft‑tissue infections, respiratory tract infections and urinary tract infections in adult patients. It is indicated for use in adults who require systemic antibacterial therapy and is formulated for oral administration.

GNH USA supplies Kyno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Minocycline Hydrochloride is employed to treat bacterial infections across several organ systems, targeting pathogens that are susceptible to tetracycline antibiotics. - Acne vulgaris: reduces inflammatory lesions and bacterial colonisation of the skin. - Skin and soft tissue infections: eradicates susceptible bacteria and promotes healing of cellulitis and abscesses. - Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible organisms. - Urinary tract infections: eliminates common uropathogens and relieves symptoms of uncomplicated cystitis.

Adverse reactions may occur with minocycline therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Photosensitivity: increased skin sensitivity to sunlight. - Dizziness: transient light‑headedness. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Drug‑induced hepatitis: elevated liver enzymes and jaundice. - Pseudotumor cerebri: increased intracranial pressure causing headache and visual changes. - Severe hypersensitivity: anaphylaxis or angioedema.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Renal function: adjust use in patients with impaired kidney function. - Hepatic function: monitor liver enzymes during prolonged treatment. - Hypersensitivity: avoid in individuals with known allergy to tetracyclines. - Photosensitizing agents: use caution when combined with other photosensitizers. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Minocycline may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Isotretinoin: increased risk of pseudotumor cerebri. - Oral anticoagulants: enhanced anticoagulant effect and bleeding risk. - Antacids containing aluminum or magnesium: reduced minocycline absorption.

Moderate Interactions (Monitor Closely): - Oral contraceptives: decreased hormonal efficacy, consider backup method. - Cyclosporine: possible increase in cyclosporine levels. - Methotrexate: heightened risk of toxicity, monitor blood counts and liver function.